Johnson & Johnson

Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation

The Wall Street Journal

Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits

Financial Times

Johnson & Johnson settles US talcum powder lawsuit with $5.5bn payout

Al Jazeera

Johnson & Johnson offers $5.5bn to settle talc cancer lawsuits

BBC News

Johnson & Johnson offers up to $5.5bn to settle US baby powder lawsuits

Sky News

J&J offers $5.5bn to settle baby powder lawsuits

ABC Australia

US pharmaceutical giant Johnson & Johnson to pay out $7.9 billion over baby powder lawsuit

VacSafety

ETHealthworld.com

US judge casts doubt on 69,000 cases alleging J&J talc caused cancer

Daily Mail

People left with cancer linked to Johnson & Johnson talcum powder 'dying every three days', High Court hears

Yahoo Finance

Johnson & Johnson reaches proposed $5.5B talcum powder settlement

Metaculus

Will Cancer Mortality By 50 By 2051

Johnson & Johnson announced a $5.5 billion agreement to resolve roughly 76,000 US lawsuits alleging its talc-based baby powder caused ovarian cancer. The deal requires acceptance by legal firms representing at least 95% of claimants before it becomes final.

Guardian

Johnson & Johnson announced a $5.5 billion agreement to resolve roughly 76,000 US lawsuits alleging its talc-based baby powder caused ovarian cancer. The deal requires acceptance by legal firms representing at least 95% of claimants before it becomes final.

J&J expects to make an initial payment of up to $3 billion in 2027, with further payments from 2028 onward. Attorney Chris Seeger, who represents about 2,500 claimants and helped negotiate the deal, said J&J could ultimately pay $7 billion or more.

J&J expects to make an initial payment of up to $3 billion in 2027, with further payments from 2028 onward. Attorney Chris Seeger, who represents about 2,500 claimants and helped negotiate the deal, said J&J could ultimately pay $7 billion or more.

The settlement follows a July 22, 2026, federal court order asking plaintiffs to show why remaining talc claims should not be dismissed after plaintiffs withdrew their specific causation experts in two bellwether cases. J&J has denied its talc products caused cancer throughout the litigation.

The settlement follows a July 22, 2026, federal court order asking plaintiffs to show why remaining talc claims should not be dismissed after plaintiffs withdrew their specific causation experts in two bellwether cases. J&J has denied its talc products caused cancer throughout the litigation.

The agreement covers nearly all remaining US talc claims and complements earlier resolutions, including settlements of about 95% of filed mesothelioma lawsuits. Unlike prior bankruptcy-based proposals, the deal applies only to existing claims and does not address future lawsuits.

The agreement covers nearly all remaining US talc claims and complements earlier resolutions, including settlements of about 95% of filed mesothelioma lawsuits. Unlike prior bankruptcy-based proposals, the deal applies only to existing claims and does not address future lawsuits.

J&J stopped selling talc-based baby powder in the US in 2020 and discontinued it globally in 2023, switching to a cornstarch-based product. In 2024, the World Health Organization classified talc as probably carcinogenic to humans.

J&J stopped selling talc-based baby powder in the US in 2020 and discontinued it globally in 2023, switching to a cornstarch-based product. In 2024, the World Health Organization classified talc as probably carcinogenic to humans.

The US settlement does not cover the United Kingdom, where a lawsuit filed at the High Court in London covers more than 7,000 potential claimants alleging J&J's talc caused ovarian cancer and mesothelioma. J&J and Kenvue UK have denied those allegations.

The US settlement does not cover the United Kingdom, where a lawsuit filed at the High Court in London covers more than 7,000 potential claimants alleging J&J's talc caused ovarian cancer and mesothelioma. J&J and Kenvue UK have denied those allegations.

Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits

Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters